低剂量伊马替尼治疗一名患有t(9;22)(q34;q11.2);BCR-ABL1的混合表型急性白血病老年患者的疗效和安全性。
Efficacy and safety of low-dose imatinib in an elderly patient with mixed phenotype acute leukemia with t(9;22)(q34;q11.2);BCR-ABL1.
作者信息
Okayama Yusuke, Takakuwa Teruhito, Otomaru Ippei, Horiuchi Mirei, Miura Akiko, Araki Taku, Fujitani Yotaro, Yamamura Ryosuke
机构信息
Department of Hematology Osaka Saiseikai Nakatsu Hospital Osaka Japan.
Department of Hematology Graduate School of Medicine Osaka City University Osaka Japan.
出版信息
Clin Case Rep. 2021 May 5;9(5):e04126. doi: 10.1002/ccr3.4126. eCollection 2021 May.
Abstract
Low-dose imatinib with monitoring of drug concentrations in blood may successfully control Philadelphia chromosome-positive mixed phenotype acute leukemia (Ph+MPAL), particularly in elderly patients with comorbidities.
摘要
低剂量伊马替尼并监测血液中的药物浓度可能成功控制费城染色体阳性混合表型急性白血病（Ph+MPAL），特别是在伴有合并症的老年患者中。
Zotero 插件